SPARROW-QUANTUM
14.3.2024 08:06:34 CET | Business Wire | Press release
ORCA Computing, Pixel Photonics, Sparrow Quantum, and the Niels Bohr Institute (NBI) announce their collaboration on the Eurostars project 'SupremeQ.' This landmark initiative brings together quantum experts from the United Kingdom, Germany, and Denmark with a shared goal of accelerating the development and commercialization of photonic quantum computing technologies to deliver quantum advantage.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313844049/en/
ORCA PT-1 computer in assembly room (Photo: Business Wire)
Supported by Eurostars, a European funding program dedicated to assisting R&D-performing SMEs in developing marketable innovative products, processes, and services, the SupremeQ project will harness world-leading expertise. It will draw upon single-photon sources from Sparrow Quantum and NBI, single-photon detectors from Pixel Photonics, and full-stack photonic quantum computing system architecture from ORCA Computing. By uniting efforts, the SupremeQ consortium aims to drive breakthrough innovation in photonic quantum computing, paving the way for quantum advantage.
According to a report by Fortune Business Insights, the quantum computing market is forecasted to reach $6.5 billion by 2030 with a CAGR of 32.1%1. With a broad range of potential application areas offering significant advantages over current classical computations. The SupremeQ project aims to address the needs of this growing market demand for quantum computing capabilities by addressing key challenges such as system engineering for scale, high acquisition, and operation costs, as well as the need for specialized expertise.
By pioneering solutions for photonic quantum computing, the project aims to unveil groundbreaking innovations in performance, packaging, and system integration. Sparrow Quantum’s single-photon sources and Pixel Photonics detectors will be engineered to co-exist within a single cryostat, marking a breakthrough in quantum computing infrastructure. With reduced complexity and enhanced component proximity, this crucial milestone heralds the path to multiplying qubits while offering considerable manufacturability and cost advantages.
ORCA Computing will draw upon its deep knowledge in quantum photonic system architecture. This expertise will be used to integrate these developments and demonstrate state-of-the-art photon processing efficiencies and reconfigurability within a standard data center rack.
These advancements are necessary for the commercialization of quantum computers to reach advantage over classical computing systems signifying a significant leap toward achieving universal fault-tolerant quantum computing.
As the quantum computing market continues to evolve, the consortium is confident that their innovative SupremeQ solutions will generate considerable interest, driving diverse applications and accelerating the widespread adoption of quantum technologies across industries well beyond the conclusion of the Eurostars program.
Consortium partners share their perspectives on the groundbreaking developments of the project:
"I envision SupremeQ as a symphony of quantum brilliance, with each partner playing a unique instrument,” stated Dr. Kurt Stokbro, CEO of Sparrow Quantum. “Together, we're composing a masterpiece that I believe will make some noise around the world."
"The advancements made possible through the SupremeQ project represent a significant leap forward in quantum computing technology," stated Nicolai Walter, CEO of Pixel Photonics. "By combining cutting-edge components and innovative architecture, we will be well-positioned to redefine the boundaries of what is possible in quantum computing."
"We are delighted to announce this new partnership with two other leading European firms,” affirmed Richard Murray, CEO of ORCA Computing. "With its unparalleled performance, the outcome of this project will spearhead new frontiers in hybrid quantum-classical computation, driving significant advancements in machine learning and optimization."
“We are thrilled to collaborate with esteemed industry partners on the SupremeQ project, which represents a significant step forward in quantum computing innovation," says Peter Lodahl, Professor at the Niels Bohr Institute.
Explore the SupremeQ project and how it will revolutionize the industry by contacting the consortium partners for more information.
Source 1: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/quantum-computing-market-104855
About ORCA Computing:
ORCA Computing, headquartered in London, UK with offices in the United States and Canada, is a leading developer and provider of full-stack photonic quantum computing systems. Established in 2019 and originating from the University of Oxford, the company provides an innovative approach to photonic quantum computing. Anchored in a modular optical fiber-based architecture, ORCA’s proprietary methods of manipulating the time, frequency and switching of single photons paves the way for quantum computing using significantly fewer components. ORCA Computing has successfully delivered numerous on-premises quantum computers to leading customers including the UK Ministry of Defence and the Poznan Supercomputing and Networking Center.
For more information, please visit www.orcacomputing.com.
About Pixel Photonics:
Pixel Photonics is a German deep-tech startup that has developed a unique approach to integrate SNSPDs (Superconducting Nanowire Single Photon Detectors) on a chip waveguide. Pixel Photonics combines the superior features of SNSPDs with the versatility of an integrated photonic platform to provide highly parallelized, efficient and ultra-fast single-photon detection. Waveguide integration enables the use of SNSPDs for photon counting, paving the way for high-performance and scalable photonic quantum computing. The Pixel Photonics team consists of 36 employees from 8 different countries.
Learn more about Pixel Photonics and the WI-SNSPD technology at www.pixelphotonics.com.
About Sparrow Quantum:
Sparrow Quantum, headquartered in Copenhagen, Denmark, is a leading provider of single-photon components enabling the photonic quantum revolution. Our flagship product, a deterministic single-photon source, sets industry standards and earns acclaim from leading quantum technology groups worldwide. With roots in over two decades of pioneering research at the Niels Bohr Institute, our technology seamlessly integrates with leading photonic quantum computing platforms and communication systems. Our dedication to advancing light-matter interfaces for quantum technologies ensures we deliver essential components for scaling up advanced quantum technology applications in information processing and communication.
Discover more about Sparrow Quantum at www.sparrowquantum.com.
About the Niels Bohr Institute, Copenhagen University:
At the Niels Bohr Institute, University of Copenhagen, we research and teach in a broad spectrum of physics areas: quantum computers and communication, astrophysics, particle physics, computational physics, solid state physics, climate and geophysics, and biophysics. In the past decade, our research in solid-state physics and quantum optics has continuously intensified with several new, large research centres. Among the latest is the Copenhagen Center for Biomedical Quantum Sensing, which will research in the development of ultra-sensitive sensors for the early detection of diseases. Last year, the Novo Nordisk Foundation Quantum Computing Program was also inaugurated, the goal of which is to develop a fully functional quantum computer within the next 12 years.
For more information, please visit www.nbi.ku.dk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240313844049/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Expands Developer Ecosystem to Accelerate the Next Era of Enterprise Digital Transformation19.2.2026 10:08:00 CET | Press release
Vonage verified Postman workspace extends reach by 40+ million developers; MCP servers and Startup Program among resources designed to further accelerate time-to-value for developers and enterprises Vonage, part of Ericsson (NASDAQ: ERIC), today announced a number of new initiatives, to further expand and enable its global developer community. By growing its developer community and tools, giving developers and enterprises access to new mobile network insights and capabilities that can be embedded into existing applications and workflows, Vonage is accelerating its strategy to transform mobile networks into a programmable platform. Putting Vonage APIs in the Hands of 40 million+ More Developers Vonage is announcing the launch of its Verified Workspace on the Postman API Network, making Vonage APIs available to the 40+ million developers who use Postman. The new, verified workspace gives Postman’s community of global developer members certified access to Vonage’s portfolio of Network API
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 202619.2.2026 08:50:00 CET | Press release
Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the selection of an abstract for a poster presentation at the American Association for Cancer Research Immuno-Oncology (AACRIO) annual conference (February 18-21, 2026), in Los Angeles. The poster showcases new preclinical data and early clinical insights from the company's lead candidate, STC-1010, supporting it as a promising therapeutic option for MSS, immune-cold colorectal cancer (CRC)—a major unmet clinical need. In a syngeneic CT26 model, murine STC-1010 significantly inhibits tumor growth and extends survival by 40%. New mechanistic datas reveal expansion of CD4⁺ and CD8⁺ T cells in draining lymph nodes alongside a significant humoral response compared to control, demonstrating coordinated cellular and humoral immune activation in vivo. Other findings show that dendritic cells efficiently capture STC-1010, leading to their activation as demonstrated by transcripto
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer19.2.2026 08:30:00 CET | Press release
Based on DESTINY-Breast05 phase 3 trial results, which showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM1 If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) as a monotherapy for adult patients with HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant HER2 targeted treatment. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committ
NHOA Energy Advances Delivery of the 51 MWh Broni Battery for Neoen in Italy19.2.2026 08:00:00 CET | Press release
The project confirms NHOA Energy’s long-term commitment to the Italian market NHOA Energy, global provider of utility-scale energy storage systems, is advancing the construction of the Broni Battery, a 10 MW/51 MWh project located in Broni (Pavia), Italy, executed for Neoen, one of the world’s leading independent producers of renewable energy. Civil works at the site are currently underway and advancing on schedule, with commissioning activities planned to start in late spring 2026. Once operational, the Broni Battery will provide essential flexibility services to the Italian electricity system, supporting grid stability and reliability as renewable energy penetration continues to increase. The project represents Neoen’s first battery storage asset in Italy and marks a strategic step in the company’s expansion, as it continues to grow its battery storage portfolio in key markets worldwide to support power system flexibility. The Broni Battery further strengthens NHOA Energy’s long-term
Compass Pathways Announces Pricing of $150 Million Public Offering19.2.2026 02:18:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the pricing of its public offering of 17,500,000 American Depositary Shares (“ADSs”) at a public offering price of $8.00 per ADS, each representing one ordinary share, and in lieu of ADSs, to certain institutional investors, pre-funded warrants to purchase up to 1,250,000 ADSs at a public offering price of $7.9999 per pre-funded warrant. In addition, Compass Pathways has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 ADSs at the public offering price, less the underwriting discounts and commissions. All of the securities are to be sold by Compass Pathways. The offering is expected to close on or about February 20, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to Compass Pathways from the offering, before deducting underwriting discounts and commissions and other est
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
